Wealth Enhancement Advisory Services, LLC Erasca, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 21,349 shares of ERAS stock, worth $52,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,349
Previous 28,139
24.13%
Holding current value
$52,518
Previous $38,000
28.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ERAS
# of Institutions
151Shares Held
217MCall Options Held
258KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$55.9 Million1.52% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.3MShares$50 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$43.9 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$36.9 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$35.7 Million0.63% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $300M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...